Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
288 Fu Te Zhong Lu, Shanghai Shi, 201208, CN
Ventyx is developing a pipeline of small molecule therapeutics designed to treat inflammation across a broad range of disease states with high unmet need.
By: Charlie Sternberg
Tharmaratnam brings nearly three decades of experience in the global CRO industry and has served as Novotech Chairman since 2021.
AstraZeneca will apply BostonGene’s omnimodal analytics to accelerate development timelines and reduce risk across its oncology portfolio.
Will advance Artis’ strategy of building a differentiated platform to accelerate gene-to-drug discovery across a range of therapeutic modalities.
Secures priority intellectual property rights around the use of HT-001 to treat dermatologic toxicities across multiple oncology treatment modalities.
Adds a Gerteis Macro-Pactor at its Whippany, NJ facility.
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production.
New and expanded facilities provide local expertise, advanced technologies, and tailored support for biopharma innovators throughout the region.
Researchers are invited to submit proposals for innovative research projects aimed at uncovering the entangled microcircuits and molecular targets disrupted in anhedonia.
The strategic investment will help ensure all key Novartis medicines for U.S. patients are manufactured in the U.S. and delivered to patients across the country at scale.
Underscores the facility’s dedication to upholding the highest standards of quality across operations.
The strategic move will enable Crown Bioscience to operate as a standalone entity under Adicon's ownership.
Aim to accelerate the development of innovative cancer therapies and increase access to clinical trials for patients across the U.S.
Stewart will lead integration of technology and process transformation initiatives across Avid's development and manufacturing network.
The authorizations cover Gobivaz 50 mg/0.5 mL and 100 mg/mL presentations in both pre-filled syringe and autoinjector formats across the UK.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
